Replies to post #20953 on Tao Synergies Inc (TAOX)

[runncoach]

Its just an exploratory endpoint really. A safety checkpoint and maybe a point of reference for the company to have an idea of any persistent benefit after dosing has stopped. It's not really relevant to primary endpoint in any way.

[Cyosol]

I don't think the second part is blinded. It's just a single checkup at week 42 to see how patients have changed after their last dose.

Blind has probably been broken by now in order to check on primary endpoints and announce topline data.